Alvotech’s Simponi Rival Begins Pharmacokinetic Study
The Icelandic Firm Is Also Expanding Its Marketing Partnership With Fuji Pharma
Alvotech’s Simponi rival enters Phase I trials after a dynamic year for the company’s development and commercialization program. Meanwhile, the biosimilars developer has also expanded its Japanese collaboration with Fuji Pharma.
